Fasting Insulin & HOMA-IR Explained
The test that catches insulin resistance years before your glucose or HbA1c budge — what it measures, how to calculate HOMA-IR, and the optimal ranges your lab report probably does not show you.
Free to use · No credit card · Works with any Australian lab
The Quick Answer
Insulin is the hormone your pancreas releases to move glucose from your bloodstream into your cells. In a healthy person, a small amount of insulin does this job efficiently. In insulin resistance, cells stop responding properly, so the pancreas has to produce far more insulin to get the same result. For years — sometimes decades — this compensatory hyperinsulinaemia keeps glucose normal while silently driving weight gain, fatty liver, elevated triglycerides, and cardiovascular risk.
Fasting insulin catches this process early by measuring how hard your pancreas is working overnight. HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) combines fasting insulin with fasting glucose into a single number that estimates overall insulin resistance. Both are available at Australian pathology labs for approximately $20-$40 private-pay.
Why Fasting Insulin Matters More Than You Think
A standard Australian diabetes screen includes fasting glucose and HbA1c. These markers are excellent at diagnosing diabetes once it is established — but by the time they rise above the diagnostic threshold, insulin resistance has typically been present for 10-20 years. The reason is straightforward: the pancreas compensates for years before it can no longer keep up.
Think of it this way: imagine a pump that normally needs to work at 30% capacity to move water through a pipe. As the pipe gradually narrows (insulin resistance), the pump starts working at 50%, 70%, 90% capacity to maintain the same flow. The output (blood glucose) looks normal right up until the pump burns out. Measuring fasting insulin is like measuring how hard the pump is working — it reveals the problem while there is still time to widen the pipe.
The HOMA-IR Formula — With Worked Examples
HOMA-IR = (fasting glucose in mmol/L × fasting insulin in mIU/L) ÷ 22.5
Excellent insulin sensitivity
Optimal metabolic health. Low risk of progression to insulin resistance or type 2 diabetes.
Good insulin sensitivity
Good metabolic health. Maintain with consistent lifestyle habits.
Early insulin resistance
Mild insulin resistance. Glucose is still normal but the pancreas is working harder than it should. Time to act.
Moderate insulin resistance
Significant insulin resistance. Elevated risk of progression to prediabetes and type 2 diabetes without intervention.
Severe insulin resistance
Severe insulin resistance. High risk. Urgent lifestyle changes and medical review are warranted.
Red Flags — Patterns That Need Attention
HOMA-IR above 2.9 with normal fasting glucose
This is the key early-warning pattern. Your glucose control looks fine, but your pancreas is working 2-3 times harder than it should. This is the ideal time to intervene - before glucose dysregulation appears.
Fasting insulin above 15 mIU/L
Even if glucose and HbA1c are normal, fasting insulin above 15 mIU/L indicates significant insulin resistance. It is associated with increased risk of NAFLD/MASLD, PCOS, elevated triglycerides, and eventual progression to prediabetes.
High HOMA-IR plus elevated ALT
ALT elevation alongside insulin resistance strongly suggests metabolic-associated steatotic liver disease (MASLD, formerly NAFLD). The liver is both a cause and a target of insulin resistance. Both markers should be tracked together.
High HOMA-IR plus high triglycerides and low HDL
This cluster - known as the insulin resistance dyslipidaemia pattern - significantly elevates cardiovascular risk. All three markers move in concert; if you have this pattern, an ApoB measurement is also warranted.
Rising HOMA-IR on repeat testing despite lifestyle changes
If HOMA-IR is not improving after 12-16 weeks of genuine dietary and exercise changes, your GP should investigate secondary causes: thyroid dysfunction, Cushing syndrome, PCOS, sleep apnoea, or medications (corticosteroids, some antipsychotics, thiazide diuretics at high dose).
How to Get Tested in Australia
Fast for 10-12 hours before the blood draw
Even a small amount of food or a sugary drink will acutely raise both glucose and insulin, completely invalidating the result. Water is fine. Black coffee or tea without sugar is acceptable but may slightly affect insulin in some people - to be safe, drink only water.
Ask your GP for fasting glucose AND fasting insulin
Fasting glucose is Medicare bulk-billed; fasting insulin is private-pay (~$20-$40). Both are done from the same blood draw. The HOMA-IR calculation requires both numbers, so there is no point testing just one without the other.
Calculate HOMA-IR yourself
Use the formula: (fasting glucose in mmol/L x fasting insulin in mIU/L) divided by 22.5. Note: some labs report insulin in pmol/L - divide by 6.945 to convert pmol/L to mIU/L before using the formula. SmarterBlood calculates this automatically when you upload your results.
Compare against optimal ranges, not just lab reference ranges
Most lab reference ranges for insulin (2-25 mIU/L) were set to cover the population distribution, not metabolic health targets. A fasting insulin of 18 mIU/L will not be flagged as abnormal on your report, but it indicates significant insulin resistance. Focus on the optimal thresholds described above.
Add context: waist circumference and other metabolic markers
Fasting insulin and HOMA-IR gain meaning alongside other markers: triglycerides above 1.7 mmol/L, HDL below 1.0 mmol/L (men) or 1.3 mmol/L (women), elevated ALT (fatty liver), and high uric acid are all associated with insulin resistance. A high TG:HDL ratio (both in mmol/L) is a cheap surrogate marker for insulin resistance when fasting insulin has not been measured.
Track the trend over time to monitor improvement
A baseline HOMA-IR gives you a starting point. After 12 weeks of lifestyle changes, a repeat fasting insulin and glucose will show whether insulin sensitivity is improving. Even a 20-30% reduction in HOMA-IR is clinically meaningful. Upload your results to SmarterBlood to plot insulin and HOMA-IR on a timeline alongside your other metabolic markers.
How to Improve Fasting Insulin and HOMA-IR
Unlike LDL or Lp(a), fasting insulin is highly responsive to lifestyle. These interventions are ranked by their typical effect size in clinical trials.
Weight loss (5-10% of body weight)
The single most effective intervention for most people. Fat stored in the liver (hepatic steatosis) is the primary driver of hepatic insulin resistance. Even modest weight loss dramatically reduces liver fat and improves insulin sensitivity.
Reducing refined carbohydrates
Refined starches and added sugars drive the largest insulin responses. Replacing them with vegetables, legumes, whole grains, and protein reduces the total insulin demand on the pancreas. A low-carbohydrate diet (below 100g total carbohydrate per day) produces the fastest initial improvements.
Resistance training
Skeletal muscle is the largest glucose sink in the body. Building muscle mass through resistance training (2-3 sessions per week) dramatically improves glucose disposal and reduces insulin requirements. Benefits persist even after individual sessions.
High-intensity interval training (HIIT)
Short bursts of high-intensity effort deplete muscle glycogen rapidly, improving glucose uptake independent of insulin (via GLUT4 translocation). Even 3 x 20-minute HIIT sessions per week produces measurable improvements in insulin sensitivity.
Improving sleep quality and duration
Even a single night of poor sleep raises fasting insulin the next morning. Chronic sleep restriction (below 6-7 hours) is an independent driver of insulin resistance. Addressing sleep apnoea, if present, often produces dramatic improvements in metabolic markers.
Time-restricted eating (TRE)
Eating within a consistent 8-10 hour window each day (without calorie restriction) has shown benefit for insulin sensitivity in multiple trials. The overnight fasting period allows insulin to drop fully, which restores insulin receptor sensitivity. Most accessible version: no eating after 7-8pm and delaying breakfast until 8-9am.
Medical Treatment Options
Lifestyle intervention is the cornerstone of treatment for insulin resistance detected at the fasting insulin/HOMA-IR stage. However, several medications can assist when lifestyle changes are insufficient:
Metformin
First-line medication for insulin resistance and prediabetes in Australia. Reduces hepatic glucose production and modestly improves insulin sensitivity. PBS-subsidised for type 2 diabetes; sometimes used off-label for prediabetes and PCOS. Note: long-term metformin use can deplete vitamin B12 - check B12 annually.
GLP-1 receptor agonists (semaglutide, dulaglutide)
Highly effective at reducing insulin resistance through weight loss and direct pancreatic and hepatic effects. PBS-subsidised for type 2 diabetes in Australia (Ozempic, Trulicity). Off-label use for obesity-related insulin resistance is increasing but not PBS-subsidised.
SGLT-2 inhibitors (empagliflozin, dapagliflozin)
Reduce blood glucose by causing the kidney to excrete glucose. Improve insulin sensitivity indirectly through weight loss and reduction of liver fat. PBS-subsidised for type 2 diabetes and heart failure.
Fasting Insulin and HOMA-IR - Frequently Asked Questions
What is fasting insulin and why is it tested?
Fasting insulin measures how much insulin your pancreas is producing when you have not eaten for at least 8-10 hours. In early insulin resistance, the body compensates by producing more insulin to keep blood glucose normal. The glucose looks fine on a standard test, but the elevated insulin signals that something is wrong. Measuring fasting insulin catches this compensatory state years before fasting glucose or HbA1c rise above the diabetic threshold.
What is the normal fasting insulin range in Australia?
Australian labs typically report fasting insulin with a reference range of 2-25 mIU/L (or pmol/L equivalent after conversion). However, the optimal range for metabolic health is considerably tighter. Most metabolic medicine specialists consider fasting insulin below 7-8 mIU/L as ideal, with below 5 mIU/L representing excellent insulin sensitivity. A result between 7-15 mIU/L suggests early insulin resistance even if the lab flags it as "normal." Above 15-25 mIU/L indicates significant insulin resistance.
What is HOMA-IR and how is it calculated?
HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It is calculated as: fasting glucose (mmol/L) multiplied by fasting insulin (mIU/L), divided by 22.5. For example, if fasting glucose is 5.2 mmol/L and fasting insulin is 9 mIU/L, then HOMA-IR = (5.2 x 9) / 22.5 = 2.08, which indicates early insulin resistance. HOMA-IR below 1.5 is optimal; 1.5-2.5 suggests mild-to-moderate resistance; above 2.5-2.9 indicates significant insulin resistance.
Is fasting insulin tested on Medicare in Australia?
Fasting insulin is not part of the standard Medicare diabetes screen, which only covers fasting glucose and HbA1c. It is typically a private-pay test costing approximately $20-$40. Fasting glucose is bulk-billed via Medicare with a valid GP referral, so if you request both together, you pay privately only for the insulin component. Most major Australian pathology labs (Dorevitch, Sullivan Nicolaides, QML, Laverty, Sonic) can perform this test.
Can you have insulin resistance with a normal HbA1c and fasting glucose?
Yes - this is the key insight behind measuring fasting insulin. In the early stages of insulin resistance, the pancreas compensates by producing much more insulin than normal. This extra insulin is enough to keep fasting glucose and HbA1c in the normal range. Both markers look fine while insulin resistance is progressing. This compensatory phase can last years or decades before glucose control eventually fails. Measuring fasting insulin and calculating HOMA-IR reveals the problem during this silent window.
What lifestyle changes improve fasting insulin and HOMA-IR?
The most effective interventions are: weight loss (even 5-10% of body weight meaningfully reduces insulin levels in overweight individuals), reducing refined carbohydrates and added sugars (the largest dietary driver of insulin demand), increasing physical activity especially resistance training and high-intensity interval training (HIIT), improving sleep quality (poor sleep raises fasting insulin within days), and reducing chronic stress. Time-restricted eating (eating within a 8-10 hour window) has shown benefit in several trials. Most people see measurable improvements in HOMA-IR within 8-12 weeks of consistent lifestyle changes.
How does insulin resistance cause weight gain and other problems?
Insulin is the primary storage hormone in the body. When cells become resistant to insulin, the pancreas produces more of it to compensate. High circulating insulin promotes fat storage (especially in the liver and abdomen), suppresses fat burning, drives hunger, raises triglycerides, lowers HDL cholesterol, promotes inflammation, and over time damages the beta cells of the pancreas. This cascade connects insulin resistance to type 2 diabetes, fatty liver disease (NAFLD/MASLD), polycystic ovary syndrome (PCOS), cardiovascular disease, and certain cancers.
Related Reading
Track Your Insulin Sensitivity Over Time
Upload your pathology PDF and SmarterBlood's AI explains your fasting insulin, glucose, HbA1c, triglycerides, and HDL in plain English — and plots them on a timeline so you can see exactly how your metabolic health is trending.
This page provides general educational information about fasting insulin and insulin resistance. It is not a substitute for professional medical advice, diagnosis, or treatment. Optimal ranges cited reflect metabolic medicine consensus and may differ from standard lab reference ranges. Always discuss abnormal results with your GP or an endocrinologist. SmarterBlood does not provide medical care.